L vs LAB · P/E 14, rev $18.45B vs rev $174.4M
Loews Corp (L) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
L currently screens at market cap $22.36B and trailing P/E 13.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the L and LAB stock pages for the full models.
Not investment advice.